Telomir Pharmaceuticals Secures $3 Million to Advance Rare Disease Drug Development
Telomir Pharmaceuticals Inc. has secured $3 million in equity financing to advance its Investigational New Drug (IND) submission for its rare disease treatment, Telomir-1.
2 minutes to read